GlassScriptPhysician profile
Jiaqi Yao
NPI 1376907766
$5,810.71
in general payments reported to CMS, 2019-2025
59 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.72 · 2021: $182 · 2022: $1,091 · 2023: $1,578 · 2024: $1,593 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,450.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $561.02 | 2021-2025 | Botox, Qulipta |
| Ucb, INC. | $367.44 | 2022-2025 | Rystiggo, Fintepla, Briviact |
| Lilly USA, LLC | $355.08 | 2022-2025 | Emgality, Amyvid, Reyvow |
| Genentech USA, INC. | $250.92 | 2022-2025 | Enspryng, Ocrevus, Ocrevus Zunovo |
| Teva Pharmaceuticals USA, INC. | $247.46 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Sk Life Science, INC. | $220.75 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $192.50 | 2022-2025 | |
| Emd Serono, INC. | $172.57 | 2023-2025 | Mavenclad, Mavenclad |
| Argenx US, INC. | $162.86 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Biogen, INC. | $145.07 | 2022-2025 | Vumerity, Skyclarys, Tysabri |
| Grifols USA, LLC | $141.61 | 2022-2025 | Gamunex-C |
| Pfizer INC. | $134.78 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $132.91 | 2022-2024 | Ultomiris |
| Mdd US Operations, LLC | $123.49 | 2024-2025 | Gocovri |
| Eisai INC. | $119.19 | 2024-2025 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiaqi Yao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.